Sandra Glucksmann, CEO of Cedilla Therapeutics and a founding board member of WEST, sat down with us to share her experience and lessons learned over her 25-year career in biotech. Sandra holds a PhD in molecular genetics and cell biology from the University of Chicago and carried out her post-doctorate work at MIT.
Sandra’s career path spanned both science and business. She attributes her success to being open to new opportunities that were not necessarily in her wheel house and to cultivating a strong network. After working as a bench scientist for eleven years at Millennium, she made a mid-career shift into the business side of biotech. She believes that staying deeply connected with her science background gave her a leg-up when developing her corporate presence in biotech.